U3 Pharma GmbH / Daiichi Sankyo Business Associe Co. Ltd. / Amgen / Daiichi Sankyo Espha Co. Ltd. / Japan Vaccine Co. Ltd. / GlaxoSmithKline K.K. History Began / U3 Pharma AG / Plexxikon Inc. / Daiichi Sankyo Healthcare Co. Ltd. / Kitasato Daiichi Sankyo Vaccine Co. Ltd. / Daiichi Pharmaceutical Co. Ltd. / Daiichi Sankyo India Pharma Private Limited / Daiichi Sankyo Inc. / Daiichi Sankyo Co. Ltd. / Asubio Pharma Co. Ltd. / Ranbaxy Laboratories Ltd. / CSR Daiichi Sankyo Healthcare Co. Ltd. / Daiichi Sankyo RD Novare Co. Ltd. / Daiichi Sankyo Korea / Eli Lilly and Company / Sankyo Co. Ltd. / The Daiichi Sankyo Group / Luitpold Pharmaceuticals Inc. / R&D Phama GmbH / Daiichi Sankyo Logistics Co. Ltd. / Daiichi Sankyo Happiness Co. Ltd. / Daiichi Sankyo ( China ) Holdings Co. Ltd. / high- Asubio Pharma / Daiichi Sankyo GmbH / ASCA Company / Daiichi Sankyo Europe GmbH / Vaccine Co. Ltd. / Message Daiichi Sankyo Espha Co. Ltd. / Daiichi Sankyo India Pharma / Daiichi Sankyo Development Ltd. / Stakeholder Trust / Daiichi Sankyo India / Japan Company Daiichi Sankyo Europe GmbH / Daiichi Sankyo Propharma Co. Ltd. / Daiichi Sankyo Pharma / Ube Industries Ltd. / Daiichi Sankyo Chemical Pharma Co. Ltd. / /
Continent
Europe / Asia / /
Country
Switzerland / Netherlands / France / Japan / Canada / Portugal / Tanzania / United Kingdom / India / Cameroon / Taiwan / Germany / Italy / West Germany / Belgium / Turkey / Austria / United States / Spain / Ireland / /
EntertainmentAwardEvent
the Ohkochi Memorial Grand Production Prize / /
Event
M&A / Name Change / Employment Change / Business Partnership / Company Expansion / FDA Phase / Product Release / Reorganization / /
Facility
Research Center / D pipeline / Science Research Centre / United States Opened Daiichi Sankyo Kusuri Museum / Now U3 Research Centre / Kasai R&D Center / Daiichi Sankyo Life Science Research Centre / Kitasato Institute / We pipeline / Daiichi Sankyo India Development Regional Activities headquarters / Plexxikon Inc. headquarters / Shinagawa R&D Center / /
IndustryTerm
drugs and medical devices / corporate social responsibility / treatment for these intractable diseases / established internal systems / pharmaceutical affairs / food products / safety management / value chain / manufacturing process / integrated initial drug discovery equipment / mail services / generic pharmaceuticals / diverse medical products / pharmaceuticals / healthcare professionals / quality healthcare / treatment of Alzheimer's disease / treatment for ischemic heart disease / manufacturing / manufacturing platforms / supply chain / marketed pharmaceuticals / business support services / treatment for osteoporosis / pharmaceutical manufacturer / generic manufacturers / latter phase / active pharmaceutical ingredients / pharmaceutical / healthcare / mobile healthcare field clinics / healthcare systems / healthcare industr / drug discovery pharmaceutical solutions / therapies innovative products / generic quality pharmaceuticals / manufacturing base / analytical services / mobile medical services / healthcare services / pharmaceuticals forms / physical infrastructure / quality pharmaceuticals / pharmaceutical customers / larger share functional skincare products / ships pharmaceuticals / /
surgery / total knee replacement surgery / hip replacement surgery / hair restoration / vaccinations / /
Organization
Research Center Munich / Science Research Centre in India / Kitasato Institute / Tatebayashi Biopharmaceuticals Center / Kasai R&D Center / U3 Research Centre / Shinagawa R&D Center / Sankyo’s mission / /
Global Executive / CEO / businessmen / President and CEO / Representative / medical representative sales promotion function / scientific adviser / first president / leader / Director / future scientific adviser / /
■H04-01 ■H1-H4 Corporate Brochure www.daiichisankyo.com